Breaking News Instant updates and real-time market news.

VTVT

vTv Therapeutics

$3.26

-0.16 (-4.68%)

16:51
04/09/18
04/09
16:51
04/09/18
16:51

vTv Therapeutics STEADFAST study misses both endpoints, study to be discontinued

vTv Therapeutics announced that results from part A of the company's Phase 3 STEADFAST study of the investigational medication azeliragon in people with mild Alzheimer's disease did not meet either co-primary efficacy endpoint. Patients taking azeliragon compared with placebo did not improve in cognitive or functional outcomes as measured by the Alzheimer's Disease Assessment Scale-cognitive subscale, or ADAS-cog, and the Clinical Dementia Rating Scale Sum of Boxes, or CDR-sb. The STEADFAST study is comprised of two independent and identical randomized, double-blind, placebo-controlled Phase 3 trials. The azeliragon treated group in part A had a 4.4 point decline from baseline in ADAS-Cog and a 1.6 point decline from baseline in CDR-sb compared to a placebo decline of 3.3 and 1.6 respectively. These differences were not statistically significant. Azeliragon was generally well-tolerated with a 25% withdrawal rate over 18 months that was similar in both the placebo and treatment arms. vTv Therapeutics is discontinuing current clinical studies involving azeliragon, including the open-label extension study and Part B of the STEADFAST study. Given the progress to date of STEADFAST Part B, the company expects that a substantial portion of the patients in Part B of STEADFAST will have completed 12 months of treatment under the study protocol. vTv Therapeutics will continue to thoroughly evaluate subset data from Part A and then the dataset from Part B over the coming weeks.

VTVT vTv Therapeutics
$3.26

-0.16 (-4.68%)

03/29/18
GHSC
03/29/18
INITIATION
Target $14
GHSC
Buy
vTv Therapeutics initiated with a Buy at Seaport Global
Seaport Global analyst Corey Davis initiated vTv Therapeutics with a Buy and $14 price target telling investors Azeliragon is a potential catalyst with the first of two Phase 3 trials in Alzheimer's expected read out in April. Davis believes vTv's current valuation is reflecting the Street's expectation of a low probability of success, which he views as a buying opportunity. If Phase 3 is positive, with a lowered discount rate of 10% from 40%, the analyst estimates shares would translate to a $45 share price, and if unsuccessful, shares could trade to the company's cash value of about 37c per share.
03/08/18
ROTH
03/08/18
INITIATION
Target $17
ROTH
Buy
vTv Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Robert LeBoyer started vTv Therapeutics with a Buy rating and $17 price target, noting that its lead product, Azeliragon, is in Phase 3 clinical trials to slow progression of Alzheimer's disease, and additional products based on its proprietary drug discovery platform are also in clinical development for type 1 and type 2 diabetes and preclinical studies.
02/08/18
02/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Q2 Holdings (QTWO) initiated with an Outperform at Wells Fargo. 2. Oasis Petroleum (OAS) initiated with an Outperform at Credit Suisse. 3. vTv Therapeutics (VTVT) initiated with an Outperform at Northland. 4. Delphi Technologies (DLPH) initiated with a Neutral at Buckingham. 5. Kennametal (KMT) re-established with an Outperform at Barrington. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/08/18
NORL
02/08/18
INITIATION
Target $28
NORL
Outperform
vTv Therapeutics initiated with an Outperform at Northland
Northland initiated vTv Therapeutics with an Outperform and $28 price target.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/14/18
08/14
13:16
08/14/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$44.28

0.77 (1.77%)

13:10
08/14/18
08/14
13:10
08/14/18
13:10
Options
Size block of calls sold in D R Horton looks closing »

Size block of calls sold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$41.80

1.72 (4.29%)

, PFGC

Performance Food Group

$38.05

1.15 (3.12%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$41.80

1.72 (4.29%)

PFGC

Performance Food Group

$38.05

1.15 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 17

    Sep

AIV

Aimco

$43.25

0.5 (1.17%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07
Conference/Events
Aimco management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

A

Agilent

$67.14

1.19 (1.80%)

, CREE

Cree

$49.96

-0.32 (-0.64%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07
Earnings
Notable companies reporting after market close »

Notable companies…

A

Agilent

$67.14

1.19 (1.80%)

CREE

Cree

$49.96

-0.32 (-0.64%)

VIAV

Viavi

$11.09

0.13 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 05

    Sep

  • 06

    Sep

  • 12

    Sep

KO

Coca-Cola

$45.93

0.11 (0.24%)

, PEP

PepsiCo

$112.80

-0.22 (-0.19%)

13:06
08/14/18
08/14
13:06
08/14/18
13:06
Hot Stocks
Coca-Cola's BodyArmor deal seen as negative for Pepsi, Keurig Dr Pepper »

In latest attempt to…

KO

Coca-Cola

$45.93

0.11 (0.24%)

PEP

PepsiCo

$112.80

-0.22 (-0.19%)

KDP

Keurig Dr Pepper

$23.61

-0.14 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$30.23

0.025 (0.08%)

, AKS

AK Steel

$4.20

-0.06 (-1.41%)

13:05
08/14/18
08/14
13:05
08/14/18
13:05
Periodicals
Canada near to imposing broad steel tariffs, Dow Jones says »

Canadian officials are…

X

U.S. Steel

$30.23

0.025 (0.08%)

AKS

AK Steel

$4.20

-0.06 (-1.41%)

NUE

Nucor

$63.53

0.4 (0.63%)

STLD

Steel Dynamics

$43.57

-0.1 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

IGT

International Game

$20.44

-0.12 (-0.58%)

13:05
08/14/18
08/14
13:05
08/14/18
13:05
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLI

Mack-Cali Realty

$19.99

0.92 (4.82%)

13:03
08/14/18
08/14
13:03
08/14/18
13:03
Periodicals
Land & Buildings likely to push for Mack-Cali sale, Bloomberg reports »

Jonathan Litt's Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$356.33

0.29 (0.08%)

, GS

Goldman Sachs

$229.95

3.12 (1.38%)

12:56
08/14/18
08/14
12:56
08/14/18
12:56
Periodicals
Goldman not hired officially by Tesla at time of tweet, Bloomberg reports »

Goldman Sachs had not…

TSLA

Tesla

$356.33

0.29 (0.08%)

GS

Goldman Sachs

$229.95

3.12 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

DOMO

Domo

$18.38

-0.1 (-0.54%)

12:53
08/14/18
08/14
12:53
08/14/18
12:53
Hot Stocks
Breaking Hot Stocks news story on Domo »

Joshua G. James reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$90.91

1.25 (1.39%)

12:50
08/14/18
08/14
12:50
08/14/18
12:50
Options
8.8K Walmart Sep 92.5 - Oct 95 call spreads bought for 29c »

8.8K Walmart Sep 92.5 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMZN

Amazon.com

$1,916.80

21.29 (1.12%)

12:49
08/14/18
08/14
12:49
08/14/18
12:49
Periodicals
U.K's ASA says Amazon Prime's one-day claim misled customers, CNBC reports »

The U.K.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 13

    Sep

CCXI

ChemoCentryx

$11.12

-1.54 (-12.16%)

12:47
08/14/18
08/14
12:47
08/14/18
12:47
Recommendations
ChemoCentryx analyst commentary  »

ChemoCentryx selloff on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$28.00

0.66 (2.41%)

12:45
08/14/18
08/14
12:45
08/14/18
12:45
Options
American Eagle call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

12:40
08/14/18
08/14
12:40
08/14/18
12:40
General news
U.S. equities are extending their rebound »

U.S. equities are…

GOOG

Alphabet

$1,240.12

5.02 (0.41%)

, GOOGL

Alphabet Class A

$1,255.80

7.04 (0.56%)

12:38
08/14/18
08/14
12:38
08/14/18
12:38
Periodicals
Alphabet invests $375M in Obamacare startup Oscar, Bloomberg reports »

Alphabet is investing…

GOOG

Alphabet

$1,240.12

5.02 (0.41%)

GOOGL

Alphabet Class A

$1,255.80

7.04 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 22

    Aug

  • 18

    Sep

  • 28

    Oct

STXB

Spirit of Texas Bancshares

$21.48

(0.00%)

12:37
08/14/18
08/14
12:37
08/14/18
12:37
Hot Stocks
Breaking Hot Stocks news story on Spirit of Texas Bancshares »

FJ Capital reports 5.21%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EKSO

Ekso Bionics

$2.84

0.16 (5.97%)

12:35
08/14/18
08/14
12:35
08/14/18
12:35
Hot Stocks
Ekso Bionics awarded $5M Department of Veterans Affairs contract 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
08/14/18
08/14
12:35
08/14/18
12:35
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

ATVI

Activision Blizzard

$71.54

1.02 (1.45%)

, EA

Electronic Arts

$131.76

0.47 (0.36%)

12:32
08/14/18
08/14
12:32
08/14/18
12:32
Hot Stocks
Game On: 'Fortnite' reportedly poses malware risk on Android »

Welcome to "Game…

ATVI

Activision Blizzard

$71.54

1.02 (1.45%)

EA

Electronic Arts

$131.76

0.47 (0.36%)

GOOG

Alphabet

$1,239.50

4.4 (0.36%)

GOOGL

Alphabet Class A

$1,255.19

6.43 (0.51%)

SSNLF

Samsung

$0.00

(0.00%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$112.93

0.82 (0.73%)

CCOEY

Capcom

$0.00

(0.00%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 22

    Aug

  • 04

    Sep

  • 10

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 28

    Oct

URBN

Urban Outfitters

$47.93

0.51 (1.08%)

12:30
08/14/18
08/14
12:30
08/14/18
12:30
Options
Put spreads in Urban Outfitters ahead of earnings next week »

Put spreads in Urban…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

YUMC

Yum China

$35.81

1.59 (4.65%)

12:25
08/14/18
08/14
12:25
08/14/18
12:25
Options
Yum China call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

ACRS

Aclaris Therapeutics

$16.86

-0.27 (-1.58%)

12:25
08/14/18
08/14
12:25
08/14/18
12:25
Conference/Events
Cantor consumer products analysts to hold analyst/industry conference call »

Analysts, along with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

CLI

Mack-Cali Realty

$19.42

0.35 (1.84%)

12:22
08/14/18
08/14
12:22
08/14/18
12:22
Periodicals
Breaking Periodicals news story on Mack-Cali Realty »

Activist investor Litt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.